Are preoperative histology and MRI useful for classification of endometrial cancer risk?

BMC Cancer

Volumn 16, Issue 1, 2016, Pages

  Body, Noemie ^a   Lavoué, Vincent ^a,b,e   De Kerdaniel, Olivier ^a   Foucher, Fabrice ^a,b   Henno, Sébastien ^b   Cauchois, Aurélie ^b   Laviolle, Bruno ^c   Leblanc, Marc ^d   Levêque, Jean ^a,b,e  

^a SERVICE DE RHUMATOLOGIE   (France)

^b CENTRE EUGÈNE MARQUIS   (France)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^d Bretagne Atlantique Hospital   (France)

^e UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Endometrial cancer; Endometrial sample; Lymphadenectomy; MRI; Risk group

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; ENDOMETRIUM CANCER; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMEDIATE RISK PATIENT; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; CLASSIFICATION; CLINICAL TRIAL; DIAGNOSTIC IMAGING; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; LYMPH NODE; LYMPH NODE METASTASIS; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PREOPERATIVE CARE; PROCEDURES; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREOPERATIVE CARE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84978646293     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-016-2554-0     Document Type: Article

References (60)

1. INCa. Cancer de l'endomètre, Boulogne-Billancourt edn: Institut National du cancer; 2010.
2. Bendifallah S, Canlorbe G, Collinet P, Arsene E, Huguet F, Coutant C, et al. Just how accurate are the major risk stratification systems for early-stage endometrial cancer? Br J Cancer. 2015;112(5):793-801.
3. Burke WM, Orr J, Leitao M, Salom E, Gehrig P, Olawaiye AB,B, et al. Endometrial cancer: a review and current management strategies: part II. Gynecol Oncol. 2014;134(2):393-402.
4. Burke WM, Orr J, Leitao M, Salom E, Gehrig P, Olawaiye AB, et al. Endometrial cancer: a review and current management strategies: part I. Gynecol Oncol. 2014;134(2):385-92.
5. Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, et al. Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2011;22 Suppl 6:vi35-9.
6. Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, et al. Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24 Suppl 6:vi33-8.
7. Creasman WT, Odicino F, Maisonneuve P, Beller U, Benedet JL, Heintz AP, et al. Carcinoma of the corpus uteri. Int J Gynaecol Obstet. 2003;83 Suppl 1:79-118.
8. Kitchener HC, Trimble EL. Endometrial cancer state of the science meeting. Int J Gynecol Cancer. 2009;19(1):134-40.
9. Raimond E, Canlorbe G, Bendifallah S, Hudry D, Selvi F, Ballester M, et al. [Endometrial carcinoma. Application of the guidelines of 2010: multicentre trial]. Bull Cancer. 2014;10(7-8):703-13.
10. Werner HM, Trovik J, Marcickiewicz J, Tingulstad S, Staff AC, Amant F, et al. Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification. Gynecol Oncol. 2012;125(1):103-8.
11. Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100(23):1707-16.
12. Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373(9658):125-36.
13. Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92(3):744-51.
14. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Warlam-Rodenhuis CC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000;355(9213):1404-11.
15. Jutzi L, Hoskins P, Lim P, Aquino-Parsons C, Tinker A, Kwon JS. The importance of adjuvant chemotherapy and pelvic radiotherapy in high-risk early stage endometrial carcinoma. Gynecol Oncol. 2013;131(3):581-5.
16. Kupets R, Le T, Bentley J, Farrell S, Fortier MP, Giede C, et al. The role of adjuvant therapy in endometrial cancer. J Obstet Gynaecol Can. 2013;35(4):375-9.
17. Foerster R, Kluck R, Rief H, Rieken S, Debus J, Lindel K. Survival of women with clear cell and papillary serous endometrial cancer after adjuvant radiotherapy. Radiat Oncol. 2014;9:141.
18. Landrum LM, Nugent EK, Zuna RE, Syzek E, Mannel RS, Moore KN, et al. Phase II trial of vaginal cuff brachytherapy followed by chemotherapy in early stage endometrial cancer patients with high-intermediate risk factors. Gynecol Oncol. 2014;132(1):50-4.
19. Kakhki VR, Shahriari S, Treglia G, Hasanzadeh M, Zakavi SR, Yousefi Z, et al. Diagnostic performance of fluorine 18 fluorodeoxyglucose positron emission tomography imaging for detection of primary lesion and staging of endometrial cancer patients: systematic review and meta-analysis of the literature. Int J Gynecol Cancer. 2013;23(9):1536-43.
20. Sawicki W, Spiewankiewicz B, Stelmachow J, Cendrowski K. The value of ultrasonography in preoperative assessment of selected prognostic factors in endometrial cancer. Eur J Gynaecol Oncol. 2003;24(3-4):293-8.
21. Selman TJ, Mann CH, Zamora J, Khan KS. A systematic review of tests for lymph node status in primary endometrial cancer. BMC Womens Health. 2008;8:8.
22. Frumovitz M, Singh DK, Meyer L, Smith DH, Wertheim I, Resnik E, et al. Predictors of final histology in patients with endometrial cancer. Gynecol Oncol. 2004;95(3):463-8.
23. Neubauer NL, Havrilesky LJ, Calingaert B, Bulusu A, Bernardini MQ, Fleming ND, et al. The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma. Gynecol Oncol. 2009;112(3):511-6.
24. Kinkel K, Forstner R, Danza FM, Oleaga L, Cunha TM, Bergman A, et al. Staging of endometrial cancer with MRI: guidelines of the European Society of Urogenital Imaging. Eur Radiol. 2009;19(7):1565-74.
25. Groff B, Pouget O, Stoll F, Mathelin C, Baldauf JJ, Akladios CY. [Pertinence of the preoperative exploration in the evaluation of the risk of lymph node metastasis in endometrial cancer]. Gynecol Obstet Fertil. 2014;42(2):92-6.
26. Dijkhuizen FP, Mol BW, Brolmann HA, Heintz AP. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer. 2000;89(8):1765-72.
27. Elsandabesee D, Greenwood P. The performance of Pipelle endometrial sampling in a dedicated postmenopausal bleeding clinic. J Obstet Gynaecol. 2005;25(1):32-4.
28. Huang GS, Gebb JS, Einstein MH, Shahabi S, Novetsky AP, Goldberg GL. Accuracy of preoperative endometrial sampling for the detection of high-grade endometrial tumors. Am J Obstet Gynecol. 2007;196(3):243. e241-245.
29. Ortoft G, Dueholm M, Mathiesen O, Hansen ES, Lundorf E, Moller C, et al. Preoperative staging of endometrial cancer using TVS, MRI, and hysteroscopy. Acta Obstet Gynecol Scand. 2013;92(5):536-45.
30. Traen K, Holund B, Mogensen O. Accuracy of preoperative tumor grade and intraoperative gross examination of myometrial invasion in patients with endometrial cancer. Acta Obstet Gynecol Scand. 2007;86(6):739-41.
31. Hirschowitz L, Nucci M, Zaino RJ. Problematic issues in the staging of endometrial, cervical and vulval carcinomas. Histopathology. 2013;62(1):176-202.
32. Sany O, Singh K, Jha S. Correlation between preoperative endometrial sampling and final endometrial cancer histology. Eur J Gynaecol Oncol. 2012;33(2):142-4.
33. Manfredi R, Mirk P, Maresca G, Margariti PA, Testa A, Zannoni GF, et al. Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology. 2004;231(2):372-8.
34. Rieck GC, Bulman J, Whitaker R, Leeson SC. A retrospective review of magnetic resonance imaging in assessing the extent of myometrial infiltration for patients with endometrial carcinoma. J Obstet Gynaecol. 2005;25(8):765-8.
35. Sala E, Crawford R, Senior E, Shaw A, Simcock B, Vrotsou K, et al. Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma. Int J Gynecol Cancer. 2009;19(1):141-6.
36. Taieb S, Ceugnart L, Leblanc E, Chevalier A, Cabaret V, Querleu D. [MR imaging of endometrial carcinoma: role and limits]. Bull Cancer. 2002;89(11):963-8.
37. Taieb S, Rocourt N, Narducci F, Ceugnart L. [Endometrial cancer imaging]. Bull Cancer. 2012;99(1):13-20.
38. Antonsen SL, Jensen LN, Loft A, Berthelsen AK, Costa J, Tabor A, et al. MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer - a multicenter prospective comparative study. Gynecol Oncol. 2013;128(2):300-8.
39. Saarelainen SK, Koobi L, Jarvenpaa R, Laurila M, Maenpaa JU. The preoperative assessment of deep myometrial invasion by three-dimensional ultrasound versus MRI in endometrial carcinoma. Acta Obstet Gynecol Scand. 2012;91(8):983-90.
40. Zamani F, Goodarzi S, Hallaji F, Zamiri A, Deilami T, Malek M, et al. Diagnostic value of pelvic MRI for assessment of the depth of myometrial invasion and cervical involvement in endometrial cancer: comparison of new versus Old FIGO staging. Iran J Radiol. 2012;9(4):202-8.
41. Ballester M, Koskas M, Coutant C, Chereau E, Seror J, Rouzier R, et al. Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy? BMC Cancer. 2010;10:465.
42. Beddy P, O'Neill AC, Yamamoto AK, Addley HC, Reinhold C, Sala E. FIGO staging system for endometrial cancer: added benefits of MR imaging. Radiographics. 2012;32(1):241-54.
43. Bendifallah S, Canlorbe G, Arsene E, Collinet P, Huguet F, Coutant C, et al. French multicenter study evaluating the risk of lymph node metastases in early-stage endometrial cancer: contribution of a risk scoring system. Ann Surg Oncol. 2015.
44. Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet. 2010;375(9721):1165-72.
45. Bendifallah S, Canlorbe G, Raimond E, Hudry D, Coutant C, Graesslin O, et al. External validation of nomograms designed to predict lymphatic dissemination in patients with early-stage endometrioid endometrial cancer: a multicenter study. Am J Obstet Gynecol. 2015;212:56. e51-57.
46. Koskas M, Bassot K, Graesslin O, Aristizabal P, Barranger E, Clavel-Chapelon F, et al. Impact of lymphovascular space invasion on a nomogram for predicting lymph node metastasis in endometrial cancer. Gynecol Oncol. 2013;129(2):292-7.
47. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103-4.
48. Werner HM, Trovik J, Marcickiewicz J, Tingulstad S, Staff AC, Engh ME, et al. A discordant histological risk classification in preoperative and operative biopsy in endometrial cancer is reflected in metastatic risk and prognosis. Eur J Cancer. 2013;49(3):625-32.
49. van der Putten LJ, Geels YP, Ezendam NP, van der Putten HW, Snijders MP, van de Poll-Franse LV, et al. Lymphovascular space invasion and the treatment of stage I endometrioid endometrial cancer. Int J Gynecol Cancer. 2015;25(1):75-80.
50. Solmaz U, Mat E, Dereli M, Turan V, Gungorduk K, Hasdemir P, et al. Lymphovascular space invasion and cervical stromal invasion are independent risk factors for nodal metastasis in endometrioid endometrial cancer. Aust N Z J Obstet Gynaecol. 2015;55(1):81-6.
51. Brun JL, Ouldamer L, Bourdel N, Huchon C, Koskas M, Gauthier T. Management of stage I endometrial cancer in France: a survey on current practice. Ann Surg Oncol. 2015.
52. Ballester M, Dubernard G, Lecuru F, Heitz D, Mathevet P, Marret H, et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol. 2011;12(5):469-76.
53. Ballester M, Naoura I, Chereau E, Seror J, Bats AS, Bricou A, et al. Sentinel node biopsy upstages patients with presumed low- and intermediate-risk endometrial cancer: results of a multicenter study. Ann Surg Oncol. 2013;20(2):407-12.
54. Darai E, Zacharopoulou C, Touboul C, Chereau E, Ballester M. [Sentinel node procedure and endometrial cancer: senti-endo results]. Bull Cancer. 2012;99(1):35-41.
55. Kang S, Yoo HJ, Hwang JH, Lim MC, Seo SS, Park SY. Sentinel lymph node biopsy in endometrial cancer: meta-analysis of 26 studies. Gynecol Oncol. 2011;123(3):522-7.
56. Koskas M, Chereau E, Ballester M, Dubernard G, Lecuru F, Heitz D, et al. Accuracy of a nomogram for prediction of lymph-node metastasis detected with conventional histopathology and ultrastaging in endometrial cancer. Br J Cancer. 2013;108(6):1267-72.
57. Naoura I, Canlorbe G, Bendifallah S, Ballester M, Darai E. Relevance of sentinel lymph node procedure for patients with high-risk endometrial cancer. Gynecol Oncol. 2015;136(1):60-4.
58. Plante M, Touhami O, Trinh XB, Renaud MC, Sebastianelli A, Grondin K, Gregoire J. Sentinel node mapping with indocyanine green and endoscopic near-infrared fluorescence imaging in endometrial cancer. A pilot study and review of the literature. Gynecol Oncol. 2015;137(3):443-7.
59. Raimond E, Ballester M, Hudry D, Bendifallah S, Darai E, Graesslin O, et al. Impact of sentinel lymph node biopsy on the therapeutic management of early-stage endometrial cancer: results of a retrospective multicenter study. Gynecol Oncol. 2014;133(3):506-11.
60. Touhami O, Trinh XB, Gregoire J, Sebastianelli A, Renaud MC, Grondin K, et al. Predictors of non-sentinel lymph node (non-SLN) metastasis in patients with sentinel lymph node (SLN) metastasis in endometrial cancer. Gynecol Oncol. 2015.